Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage

Prenatal Diagnosis

Volumn 36, Issue 4, 2016, Pages 312-320

  Parks, Michael ^a   Court, Samantha ^a   Cleary, Siobhan ^a   Clokie, Samuel ^a   Hewitt, Julie ^a   Williams, Denise ^a   Cole, Trevor ^a   Macdonald, Fiona ^a   Griffiths, Mike ^a   Allen, Stephanie ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; DMD PROTEIN, HUMAN; DNA; DYSTROPHIN; GENETIC MARKER;

ARTICLE; BECKER MUSCULAR DYSTROPHY; CASE REPORT; CHORION VILLUS SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA EXTRACTION; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIN GENE; FEMALE; FETUS; GENE; GENE DOSAGE; GENE SEQUENCE; GENETIC RECOMBINATION; HAPLOTYPE; HUMAN; MALE; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RELIABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME; X CHROMOSOME LINKED DISORDER; BLOOD; CASE CONTROL STUDY; CELL FREE SYSTEM; GENETIC MARKER; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; MATERNAL SERUM SCREENING TEST; MUSCULAR DYSTROPHY, DUCHENNE; PREGNANCY; PROCEDURES;

CASE-CONTROL STUDIES; CELL-FREE SYSTEM; DNA; DYSTROPHIN; FEMALE; GENETIC MARKERS; GENETIC TESTING; HAPLOTYPES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MATERNAL SERUM SCREENING TESTS; MUSCULAR DYSTROPHY, DUCHENNE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 84959432144     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4781     Document Type: Article

References (39)

1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet Lond Engl 1997;350:485-7.
2. Daley R, Hill M, Chitty LS. Non-invasive prenatal diagnosis: progress and potential. Arch Dis Child - Fetal Neonatal Ed 2014;99:F426-F430.
3. Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007;27:415-8.
4. Lun FMF, Chiu RWK, Allen Chan KC, et al. Microfluidics Digital PCR Reveals a Higher than Expected Fraction of Fetal DNA in Maternal Plasma. Clin Chem 2008;54:1664-1672.
5. Barrett AN, Zimmermann BG, Wang D, et al. Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield. PLoS One 2011;6(10):e25202.
6. Van der Schoot CE, Hahn S, Chitty LS. Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008;13:63-8.
7. Bombard AT, Akolekar R, Farkas DH, et al. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn 2011;31:802-8.
8. Devaney SA, Palomaki GE, Scott JA, et al. Noninvasive Fetal Sex Determination Using Cell-Free Fetal DNA: A Systematic Review and Meta-analysis. JAMA 2011;306:. DOI: 10.1001/jama.2011.1114.
9. Hill M, Lewis C, Jenkins L, et al. Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom. Expert Opin Biol Ther 2012;12(Suppl 1):S119-126.
10. Hill M, Twiss P, Verhoef TI, et al. Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis. Prenat Diagn 2015;35:950-8. DOI: 10.1002/pd.4585.
11. Chitty LS, Mason S, Barrett AN, et al. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach: Non-invasive prenatal diagnosis using next-generation sequencing. Prenat Diagn 2015;35:656-662.
12. Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:20458-20463.
13. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing. Obstet Gynecol 2012;119:890-901.
14. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples: Initial clinical laboratory experience with noninvasive prenatal DNA testing. Prenat Diagn 2013;33:569-574.
15. Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014;211:365.e1-365.e12.
16. Bustamante-Aragonés A, Rodríguez de Alba M, Perlado S, et al. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene 2012;504:144-9.
17. Lench N, Barrett A, Fielding S, et al. The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made: Non-invasive prenatal diagnosis of single-gene disorders. Prenat Diagn 2013;33:555-562.
18. Tsui NBY, Kadir RA, Chan KCA, et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011;117:3684-91.
19. Lam K-WG, Jiang P, Liao GJW, et al. Noninvasive Prenatal Diagnosis of Monogenic Diseases by Targeted Massively Parallel Sequencing of Maternal Plasma: Application to -Thalassemia. Clin Chem 2012;58:1467-75.
20. New MI, Tong YK, Yuen T, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab 2014;99:E1022-30.
21. Ma D, Ge H, Li X, et al. Haplotype-based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing. Gene 2014;544:252-8.
22. Xu Y, Li X, Ge H, et al. Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma. Genet Med 2015. DOI: 10.1038/gim.2014.207.
23. Papasavva T, vanIJcken WFJ, Kockx CEM, et al. Next generation sequencing of SNPs for non-invasive prenatal diagnosis: challenges and feasibility as illustrated by an application to β-thalassaemia. Eur J Hum Genet 2013;21:1403-10.
24. Lo YMD, Chan KCA, Sun H, et al. Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus. Sci Transl Med 2010;2:61ra91-61ra91.
25. Worton RG, Thompson MW. Genetics of Duchenne muscular dystrophy. Annu Rev Genet 1988;22:601-29.
26. Prior TW, Bridgeman SJ. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn 2005;7:317-326.
27. Tuffery-Giraud S, Béroud C, Leturcq F, et al. Genotype-phenotype analysis in 2, 405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat 2009;30:934-945.
28. Abbs S, Tuffery-Giraud S, Bakker E, et al. Best Practice Guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscul Disord 2010;20:422-7.
29. O'Leary P, Maxwell S, Murch A, et al. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies. Aust N Z J Obstet Gynaecol 2013;53:425-433.
30. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27:1-7.
31. Abbs S, Roberts RG, Mathew CG, et al. Accurate assessment of intragenic recombination frequency within the Duchenne muscular dystrophy gene. Genomics 1990;7:602-6.
32. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-205.e11.
33. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med 2011;13:913-920.
34. Canick JA, Palomaki GE, Kloza EM, et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies: Fetal fraction and non-invasive testing. Prenat Diagn 2013;33:667-674.
35. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-137.e8.
36. Jensen TJ, Zwiefelhofer T, Tim RC, et al. High-Throughput Massively Parallel Sequencing for Fetal Aneuploidy Detection from Maternal Plasma. PLoS One 2013;8(3):e57381.
37. Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014;211:527.e1-527.e17.
38. Allyse M, Minear M, Rote M, et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health 2015;7:113-26.
39. Van Schendel RV, Kleinveld JH, Dondorp WJ, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet EJHG 2014;22:1345-50.